Promise seen in possible treatment for autism spectrum disorder
November 1, 2017
Human chromosome 16p11.2 deletion syndrome is caused by the absence of about 27 genes on chromosome 16. This deletion is characterized by intellectual disability; impaired language, communication, and socialization skills; and autism spectrum disorder or ASD.
Research from the laboratories of Mark Bear at MIT and Jacqueline Crawley at the University of California at Davis, has identified a potential therapeutic for ASD. Researchers found that R-Baclofen reverses cognitive deficits and improves social interactions in two lines of 16p11.2 deletion mice.
https://medicalxpress.com/news/2017-11-treatment-autism-spectrum-disorder.html?utm_source=tabs&utm_medium=link&utm_campaign=story-tabs
